Porphyrin modified trastuzumab improves efficacy of HER2 targeted photodynamic therapy of gastric cancer
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Cancer"
DOI: 10.1002/ijc.30844
Abstract: Gastric cancer (GC) is the 3rd deadliest cancer worldwide, due to limited treatment options and late diagnosis. Human epidermal growth factor receptor‐2 (HER2) is overexpressed in ∼20% of GC cases and anti‐HER2 antibody trastuzumab in… read more here.
Keywords: therapy; her2 positive; gastric cancer; trast porph ... See more keywords